← BICYCLE THERAPEUTICS PLC BCYC
Market Price
$3.90
Market Cap
$276.04M
P/E Ratio
N/A
Revenue (FY 2025)
↑105.8% YoY
$72.59M
3-Yr CAGR: 71.2%
Net Income
↓-29.5% YoY
-$218.96M
Net Margin: -301.7%
Free Cash Flow
↓-51.9% YoY
-$252.03M
FCF Yield: -91.30%
EPS (Diluted)
↓-9.0% YoY
$-3.16
Basic: $-3.16
Return on Equity
Efficiency
-35.9%
ROA: -30.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (BCYC)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2018: Revenue YoY (+246.4%) is identical to Gross Profit YoY (+246.4%). Verify the underlying Revenue and Gross Profit values for FY 2018 and FY 2017.
- FY 2019: Revenue YoY (+93.4%) is identical to Gross Profit YoY (+93.4%). Verify the underlying Revenue and Gross Profit values for FY 2019 and FY 2018.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | $2.1M | — | $2.1M | $-16.3M | — | $-48.81 | — | $-1.4M | $-2.5M | — |
| FY 2018 | $7.1M | +246.4% | $7.1M | $-21.8M | -34.4% | $-49.78 | -2.0% | $-26.1M | $-27.3M | -978.5% |
| FY 2019 | $13.8M | +93.4% | $13.8M | $-30.6M | -40.1% | $-2.77 | +94.4% | $-28.6M | $-30.2M | -10.7% |
| FY 2020 | $10.4M | -24.7% | $9.9M | $-51.0M | -66.7% | $-2.66 | +4.0% | $-17.8M | $-19.0M | +37.1% |
| FY 2021 | $11.7M | +12.6% | $8.7M | $-66.8M | -31.0% | $-2.67 | -0.4% | $-14.8M | $-16.8M | +11.4% |
| FY 2022 | $14.5M | +23.6% | $11.1M | $-112.7M | -68.7% | $-3.80 | -42.3% | $-86.1M | $-105.1M | -524.7% |
| FY 2023 | $27.0M | +86.5% | $23.7M | $-180.7M | -60.3% | $-5.08 | -33.7% | $-60.6M | $-63.6M | +39.5% |
| FY 2024 | $35.3M | +30.8% | $33.5M | $-169.0M | +6.4% | $-2.90 | +42.9% | $-164.7M | $-166.0M | -161.1% |
| FY 2025 | $72.6M | +105.8% | $72.4M | $-219.0M | -29.5% | $-3.16 | -9.0% | $-249.7M | $-252.0M | -51.9% |
Valuation
Market Price
$3.90
Market Cap
$276.04M
Enterprise Value
-$321.12M
P/E Ratio
N/A
P/B Ratio
0.45
FCF Yield
-91.30%
Dividend Yield
0.00%
Shares Outstanding
Profitability & Margins
Gross Margin
99.72%
Operating Margin
-340.38%
Net Margin
-301.66%
Return on Equity (ROE)
-35.90%
Return on Assets (ROA)
-30.51%
Asset Turnover
0.10x
Revenue 3-Yr CAGR
71.21%
Financial Health & Liquidity
Current Ratio
0.43
Cash Ratio
14.16
Debt / Equity
0.051
Debt / Assets
0.043
Cash & Equivalents
$628.11M
Total Debt
$30.95M
Book Value / Share
$8.75
Cash Flow Efficiency
Operating Cash Flow
-$249.68M
Capital Expenditures (CapEx)
$2.35M
Free Cash Flow
-$252.03M
OCF / Revenue
-343.97%
FCF / Revenue
-347.21%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-3.16
EPS (Basic)
$-3.16
Dividends / Share
N/A
Book Value / Share
$8.75
EPS YoY Growth
-8.97%
Balance Sheet (FY 2025)
Total Assets
$717.60M
Total Liabilities
$107.62M
Stockholders' Equity
$609.98M
Current Assets
$19.18M
Current Liabilities
$44.35M